Novabay(NBY)05-10 04:25
$Novabay(NBY)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-24-015679 Act: 34 Size: 10 MB 网页链接查看全文
智通财经APP获悉,美股周一盘前,NovaBay(NBY.US)发布了2019Q2财报,该生物制药公司专注于将 Avenova 商业化用于国内眼部护理市场。 根据财报,期内,公司净销售额为180万美元;Avenova销售额为160万美元,环比增长9%。 该公司总裁兼首... 网页链接
格隆汇6月11日丨NovaBay(NBY)今日盘前涨39.03%,报6.31美元,昨日大涨874.84%。NovaBay是一家专注眼部护理市场的生物制药公司,专注于其非抗生素抗感染产品的商业化和开发,以满足全球局部抗感染市场尚未得到满足的治疗需求,其主推产品之一... 网页链接
5月10日Novabay制药(股票代码:NBY)公布财报,公告显示公司2018财年第一财季净利润为-215.00万美元,同比增长46.4%;营业收入为294.70万美元,同比下跌20.37%。 NovabayPharmaceutic ... 网页链接
$Novabay制药(NBY)$ 10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-04-12 AccNo: 0001437749-19-007095 Size: 165 KB 网页链接
$Novabay制药(NBY)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2019-04-01 AccNo: 0001437749-19-006266 Size: 340 KB 网页链接
$Novabay制药(NBY)$ 8-K - Current report Filed: 2019-04-01 AccNo: 0001437749-19-006128 Size: 261 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhi...
$Novabay制药(NBY)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-03-29 AccNo: 0001437749-19-006017 Size: 11 MB 网页链接
$Novabay制药(NBY)$ 8-K - Current report Filed: 2019-03-28 AccNo: 0001437749-19-005842 Size: 288 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a RegistrantI...
$Novabay制药(NBY)$ 美东时间 2019-03-28 盘后 披露财报,预期EPS -0.14 网页链接
$Novabay制药(NBY)$ 8-K - Current report Filed: 2019-03-12 AccNo: 0001437749-19-004683 Size: 76 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Novabay制药(NBY)$ SEC STAFF ACTION - SEC Staff Action: ORDER Filed: 2019-03-11 AccNo: 9999999997-19-000958 Size: 92 KB 网页链接
$Novabay制药(NBY)$ 8-K - Current report Filed: 2019-03-11 AccNo: 0001437749-19-004563 Size: 25 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Novabay制药(NBY)$ 8-K - Current report Filed: 2019-03-01 AccNo: 0001437749-19-003783 Size: 165 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a RegistrantI...